JNJ Sentiment Analysis

Johnson & Johnson Settles Talc Baby Powder Lawsuit in January 2025

Published on January 2, 2025

Johnson & Johnson (JNJ) has recently reached a settlement in the longstanding talc powder ovarian cancer lawsuit....

Talc Baby Powder Lawsuit: January 2025 Settlement Update

Published on January 2, 2025

Recent updates on the ongoing Talc Baby Powder Lawsuit against Johnson & Johnson (JNJ) reveal progress towards a possible settlement. The lawsuit, which accuses the company's talc powder products of causing ovarian cancer, has been a widely debated t...

Investors Still Waiting For A Pull Back In Johnson & Johnson NYSE:JNJ

Published on January 1, 2025

Johnson & Johnson (NYSE:JNJ) has been on an upward trend in the market while other stocks have been facing a fall....

Hedge Funds Bet Big On Johnson & Johnson: Top Healthcare Stock to Watch

Published on November 30, 2024

Hedge funds have made a significant investment in Johnson & Johnson (JNJ), making it a top healthcare stock to watch....

How Johnson & Johnson is improving access to medicine and medical supply

Published on November 20, 2024

Johnson & Johnson (JNJ) has been taking significant steps to improve access to medicine and medical supplies for people around the world who need them the most. The company has been actively partnering with organizations and governments to provide be...

Johnson & Johnson Takes the 340B Rebate Plan to Court: A Legal Battle for Access to Healthcare

Published on November 19, 2024

Johnson & Johnson has recently filed a lawsuit against the federal government, challenging the halt of their 340B rebate plan....

Johnson & Johnson Enters Oversold Territory as J&J Sues HHS over 340B Payment Terms

Published on November 18, 2024

Johnson & Johnson (J&J) is making headlines as it sues the U.S....

Johnson & Johnson Seeks Approval for DARZALEX FASPRO as Monotherapy for Smoldering Multiple Myeloma

Published on November 10, 2024

Johnson & Johnson has recently submitted applications in the U.S....

Johnson & Johnson Faces Legal Challenges and Resignation of CIO Larry Jones

Published on November 7, 2024

Johnson & Johnson (JNJ) is currently experiencing significant legal challenges and internal changes, raising concerns among investors. The company has been dealing with numerous lawsuits related to its talc baby powder, with allegations of causing ov...

Judge's Decision: JNJ's $8.2B Talc Settlement Offer in 2025 awaits Verdict

Published on November 6, 2024

Johnson & Johnson's journey through the talc powder lawsuit continues as a Judge is set to decide the fate of their $8....

US Government Moves to Block JJ Talc Bankruptcy Resolution, Impacts JNJ Johnson & Johnson's Future

Published on November 6, 2024

JNJ Johnson & Johnson, a renowned pharmaceutical and consumer goods company, faces a major setback as the US government steps in to block JJ Talc's bankruptcy resolution. The company has been dealing with numerous lawsuits related to allegations that...

Top Stock Reports for JNJ JOHNSON & JOHNSON Yahoo Finance

Published on November 5, 2024

According to the latest stock reports on Yahoo Finance, JNJ JOHNSON & JOHNSON is predicted to have a strong performance in the coming months. Analysts forecast that the company's stock will experience significant growth due to its ongoing successful ...

US Government Blocks JJ's Talc Bankruptcy Resolution, Stocks Prognosis Recommends to Buy

Published on November 4, 2024

JJ Johnson & Johnson's plans to resolve its talc bankruptcy issue have hit a roadblock as the US government intervenes....

US government moves to block JJ talc bankruptcy resolution

Published on November 3, 2024

The US government has taken legal action to block Johnson & Johnson's proposed bankruptcy resolution regarding its talc lawsuits....

JJ Medtech CIO Larry Jones resigns

Published on November 2, 2024

J&J Medtech's Chief Information Officer, Larry Jones, has announced his resignation....

Something Really Bad Happened: JJs Talc Bankruptcy Vote Under Attack

Published on November 1, 2024

In a shocking turn of events, Johnson & Johnson (JNJ) faced a major setback as its talc bankruptcy vote came under attack....

Johnson & Johnson's Blockbuster Drug Tremfya Clears Plaque Psoriasis With Lesions Covering Body's Smaller Areas

Published on November 1, 2024

Johnson & Johnson has achieved a significant milestone with its blockbuster drug Tremfya, which has successfully cleared plaque psoriasis with lesions covering smaller areas of the body. The drug, which is part of the company's dermatology portfolio,...

J&J's Innovation Incubator Appoints New Leader in D.C.

Published on October 30, 2024

The Johnson & Johnson Company's innovation incubator, known as Johnson & Johnson Innovation, has announced the appointment of a new head for its D.C. branch. The incubator aims to support and nurture startups in the healthcare industry by providing f...

Decoding Johnson & Johnson JNJ: A Strategic SWOT Insight

Published on October 30, 2024

Johnson & Johnson (JNJ) is a well-known multinational medical devices, pharmaceutical, and consumer packaged goods manufacturing company. With a history spanning over 130 years, JNJ has established itself as a leader in the healthcare industry. Recen...

JOHNSON & JOHNSON Stock Hits Price Target Forecast, Yielding Profit of 5.71%

Published on July 25, 2024

JOHNSON & JOHNSON (JNJ) investors have seen their patience pay off as the stock recently hit the price target forecast provided by QuantWave, resulting in a profit of 5.71%. The forecast signal was issued on July 16, 2024, with the stock trading at 1...